Drawing on a rich set of interviews and surveys, this book shows how the global AIDS treatment advocacy movement helped millions in the developing world gain access to life-saving medication. The movement achieved this by transforming the market for AIDS drugs from one which was 'low volume, high price' to one based on access for all. The authors suggest that a movement's ability to transform markets depends upon whether: (1) markets are contestable; (2) they have framed their arguments to resonate across their target audiences; (3) the movement itself has a coherent goal; (4) the costs are low, or the benefit-to-cost ratio is favourable; and, finally, (5) institutions are present to reward continued achievement of the new market principle. These insights are applied to a range of other cases including malaria, maternal mortality, water/diarrheal disease, non-communicable diseases, education, climate change, the ivory trade, sex trafficking and the Atlantic slave trade.
Ethan B. Kapstein is Arizona Centennial Professor of International Affairs at the McCain Institute of International Leadership, Arizona State University. He is also a Visiting Fellow at the Center for Global Development in Washington DC. A former naval officer and international banker, Kapstein is the author or editor of ten books and scores of professional articles including The Fate of Young Democracies (Cambridge University Press, 2008). Joshua W. Busby is an Assistant Professor in the Lyndon B. Johnson School of Public Affairs at the University of Texas, Austin. He is also the Crook Distinguished Scholar at the Robert S. Strauss Center for International Security and Law. He has published widely on social movements, global health, climate change and US foreign policy, including Moral Movements and Foreign Policy (Cambridge University Press, 2010).
1. Introduction: global markets and transnational social movements; Appendix A. A brief history of AIDS and the AIDS treatment movement; Appendix B. Key dates; 2. Industry structure and movement opportunities; 3. Drugs = life: framing access to AIDS drugs; 4. Movement coherence and mobilization; 5. Advocacy strategies to address costs; 6. Institutions to stabilize the market; 7. Lessons for other campaigns; 8. Conclusions: implications for research and policy.